Literature DB >> 16030105

Genetic variants of DNA repair genes and prostate cancer: a population-based study.

Jamie D Ritchey1, Wen-Yi Huang, Anand P Chokkalingam, Yu-Tang Gao, Jie Deng, Paul Levine, Frank Z Stanczyk, Ann W Hsing.   

Abstract

As part of a population-based case-control study in Shanghai, China, we investigated whether variants in several DNA repair genes, either alone or in conjunction with other risk factors, are associated with prostate cancer risk. Genomic DNA from 162 patients newly diagnosed with prostate cancer and 251 healthy men randomly selected from the population were typed for five nonsynonymous DNA repair markers. We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively]. In contrast, XRCC3-Thr241Met, XPD-Lys751Gln, and MGMT-Ile143Val markers showed no significant associations with risk, although due to the much lower frequency of their variant alleles in this population we cannot rule out small to modest effects. There was a significant interaction between the MGMT-84 marker and insulin resistance (P(interaction) = 0.046). Relative to men with the MGMT-84 CC genotype and a low insulin resistance (<0.097), those having the CT-TT genotype and a greater insulin resistance had a 5.4-fold risk (OR, 5.39; 95% CI, 2.46-11.82). In addition, for the XRCC3-241 marker, relative to men with the CC genotype and a low intake of preserved foods (<12.7 g/d), those harboring the CT+TT genotype and having a higher intake of preserved foods (>12.7 g/d), which contain nitrosamines and nitrosamine precursors, had a significantly increased risk of prostate cancer risk (OR, 2.62; 95% CI, 1.13-6.06). In contrast, men with the CT+TT genotype and a low intake of preserved foods had a 69% reduction in risk (OR, 0.31; 95% CI, 0.10-0.96; P(interaction) = 0.005). These results suggest that genetic variants in the DNA repair pathways may be involved in prostate cancer etiology and that other risk factors, including preserved foods and insulin resistance, may modulate prostate cancer risk in combination with genetic susceptibility in these repair pathways. Replication in larger studies is necessary to preclude chance findings, particularly those among subgroups, and clarify the mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030105     DOI: 10.1158/1055-9965.EPI-04-0809

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Authors:  Shao-Guang Liao; Lu Liu; Ying Wang; Ying-Yi Zhang; Ya-Jie Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-29       Impact factor: 4.553

2.  Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.

Authors:  H-W Wang; Z-K Xu; Y Song; Y-G Liu
Journal:  Cancer Gene Ther       Date:  2017-04-14       Impact factor: 5.987

3.  DNA damage phenotype and prostate cancer risk.

Authors:  O Kosti; L Goldman; D T Saha; R A Orden; A J Pollock; H L Madej; A W Hsing; L W Chu; J H Lynch; R Goldman
Journal:  Mutat Res       Date:  2010-11-21       Impact factor: 2.433

Review 4.  Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.

Authors:  Jong Y Park; Yifan Huang; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

5.  The Thr241Met polymorphism in the XRCC3 gene is associated with increased risk of cancer in Chinese mainland populations.

Authors:  Liang Du; Tianyuan Xiong; Qing He; Yayi Wang; Jiani Shen; Yuanling Peng; Qingyi Jia; Jiqiao Yang; Yonggang Zhang; Jin Huang
Journal:  Tumour Biol       Date:  2013-11-07

Review 6.  Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.

Authors:  Yue Hu; Min Zhou; Kang Li; Kai Zhang; Xiangquan Kong; Yamei Zheng; Jianxu Li; Li Liu
Journal:  Tumour Biol       Date:  2013-11-08

7.  The association of XRCC3 Thr241Met genetic variant with risk of prostate cancer: a meta-analysis.

Authors:  Gao Xuan; Ying Hui; He Fang
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

8.  Association of genetic and non-genetic risk factors with the development of prostate cancer in Malaysian men.

Authors:  Khamsigan Munretnam; Livy Alex; Nurul Hanis Ramzi; Jagdish Kaur Chahil; I S Kavitha; Nikman Adli Nor Hashim; Say Hean Lye; Sharmila Velapasamy; Lian Wee Ler
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

9.  Differential inactivation of polymorphic variants of human O6-alkylguanine-DNA alkyltransferase.

Authors:  Qingming Fang; Natalia A Loktionova; Robert C Moschel; Sahar Javanmard; Gary T Pauly; Anthony E Pegg
Journal:  Biochem Pharmacol       Date:  2007-10-02       Impact factor: 5.858

10.  Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.

Authors:  Ilir Agalliu; Erika M Kwon; Claudia A Salinas; Joseph S Koopmeiners; Elaine A Ostrander; Janet L Stanford
Journal:  Cancer Causes Control       Date:  2009-11-10       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.